GB201316049D0 - Excipient system for topical delivery of pharmaceutical agents - Google Patents

Excipient system for topical delivery of pharmaceutical agents

Info

Publication number
GB201316049D0
GB201316049D0 GBGB1316049.4A GB201316049A GB201316049D0 GB 201316049 D0 GB201316049 D0 GB 201316049D0 GB 201316049 A GB201316049 A GB 201316049A GB 201316049 D0 GB201316049 D0 GB 201316049D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical agents
topical delivery
excipient system
excipient
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1316049.4A
Other versions
GB2507639A (en
GB2507639B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ad Lunam Labs Inc
Original Assignee
Ad Lunam Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ad Lunam Labs Inc filed Critical Ad Lunam Labs Inc
Publication of GB201316049D0 publication Critical patent/GB201316049D0/en
Publication of GB2507639A publication Critical patent/GB2507639A/en
Application granted granted Critical
Publication of GB2507639B publication Critical patent/GB2507639B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB1316049.4A 2012-09-10 2013-09-10 Antifungal serum comprising alkyl lactate and simmondsia chinesis seed oil Active GB2507639B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261698875P 2012-09-10 2012-09-10
US201261698898P 2012-09-10 2012-09-10

Publications (3)

Publication Number Publication Date
GB201316049D0 true GB201316049D0 (en) 2013-10-23
GB2507639A GB2507639A (en) 2014-05-07
GB2507639B GB2507639B (en) 2019-02-13

Family

ID=49486960

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1316049.4A Active GB2507639B (en) 2012-09-10 2013-09-10 Antifungal serum comprising alkyl lactate and simmondsia chinesis seed oil

Country Status (4)

Country Link
AU (2) AU2013227981B2 (en)
CA (1) CA2826708A1 (en)
GB (1) GB2507639B (en)
ZA (1) ZA201306823B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106659647A (en) * 2014-06-30 2017-05-10 强生消费者公司 Minoxidil-containing hair growth composition
CN108472511A (en) * 2015-12-28 2018-08-31 强生消费者公司 Hair growth stimulant compositions and method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810498A (en) * 1986-02-13 1989-03-07 The Peau Corporation Nail oil composition
WO2004064769A2 (en) * 2003-01-21 2004-08-05 Hector Herrera Methods for making and using topical delivery agents
US7094432B2 (en) * 2003-02-10 2006-08-22 Revlon Consumer Products Corporation Cosmetic compositions containing Rooibus tea extract
EP1631248A1 (en) * 2003-05-30 2006-03-08 Gianfranco De Paoli Ambrosi A formulation for chemical peeling
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
WO2008034178A1 (en) * 2006-09-21 2008-03-27 Salvatore Iemma Topical depilating composition
US8691247B2 (en) * 2006-12-26 2014-04-08 Ad Lunam Labs Inc. Skin rejuvenation cream

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106659647A (en) * 2014-06-30 2017-05-10 强生消费者公司 Minoxidil-containing hair growth composition
CN106659647B (en) * 2014-06-30 2021-04-02 强生消费者公司 Minoxidil-containing hair growth composition
CN108472511A (en) * 2015-12-28 2018-08-31 强生消费者公司 Hair growth stimulant compositions and method

Also Published As

Publication number Publication date
CA2826708A1 (en) 2014-03-10
AU2017272269A1 (en) 2018-01-04
AU2013227981A1 (en) 2014-03-27
GB2507639A (en) 2014-05-07
ZA201306823B (en) 2014-05-28
AU2013227981B2 (en) 2017-09-14
GB2507639B (en) 2019-02-13
AU2017272269B2 (en) 2019-02-07

Similar Documents

Publication Publication Date Title
HK1206634A1 (en) Vehicles for controlled delivery of different pharmaceutical agents
ZA201502352B (en) Liposomal drug delivery system
HK1206297A1 (en) Pharmaceutical compositions for combination therapy
HK1205010A1 (en) System for delivering medication
EP2849770A4 (en) Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
HK1205462A1 (en) Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative
HRP20190050T1 (en) Pharmaceutical compositions for combination therapy
EP2921152A4 (en) Drug dispensing system
HK1204258A1 (en) Drug dispensing system
HK1205146A1 (en) Pharmaceutical formulation
ZA201309156B (en) Drug delivery system
ZA201405797B (en) Pharmaceutical dosage form
AP2015008208A0 (en) Pharmaceutical administration forms comprising
IL227651A (en) Pharmaceutical formulation for topical administration comprising b220
GB201316049D0 (en) Excipient system for topical delivery of pharmaceutical agents
EP2917860A4 (en) Drug dispensing system
EP2852378A4 (en) Copolymer-xerogel nanocomposites useful for drug delivery
EP2873422A4 (en) Pharmaceutical preparation for injection
ZA201502354B (en) Pharmaceutical dosage form
EP2768488A4 (en) Two phase pharmaceutical delivery system
GB201204597D0 (en) Topical pharmaceutical formulation
HUE043019T2 (en) Pharmaceutical compositions for combination therapy
GB201416458D0 (en) Drug delivery system for finasteride to prostate
GB201110227D0 (en) Improvements relating to systems for administering medicaments